Direxion Daily S&P Biotech Bear 3X ETF
LABD
9 hedge funds and large institutions have $3.98M invested in Direxion Daily S&P Biotech Bear 3X ETF in 2016 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 1 closing their positions.
348% more call options, than puts
Call options by funds: $4.93M | Put options by funds: $1.1M
300% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 1
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
175% more capital invested
Capital invested by funds: $1.45M → $3.98M (+$2.53M)
50% more funds holding
Funds holding: 6 → 9 (+3)
0% more ownership
Funds ownership: 0% → 0% (+0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$2.62M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$468K |
| 3 |
Jane Street
New York
|
+$468K |
| 4 |
VKH
Virtu KCG Holdings
New York
|
+$468K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
+$281K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FTUS
Flow Traders U.S.
New York
|
-$93.5K |
| 2 |
Morgan Stanley
New York
|
-$93.5K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
VF
1
Virtu Financial
New York
| $1.94M | +$2.62M | +56 | New |
|
|
2
Jane Street
New York
| $653K | +$468K | +10 | +111% |
|
|
3
Citadel Advisors
Miami,
Florida
| $356K | +$468K | +10 | New |
|
|
4
Simplex Trading
Chicago,
Illinois
| $343K | +$281K | +6 | +150% |
|
|
VKH
5
Virtu KCG Holdings
New York
| $335K | +$468K | +10 | New |
|
|
TRCT
6
Tower Research Capital (TRC)
New York
| $194K | +$281K | +6 | New |
|
|
CG
7
Cutler Group
San Francisco,
California
| $51K | +$46.8K | +1 | +100% |
|
8
UBS Group
Zurich,
Switzerland
| $38K | – | – | – |
|
|
9
Morgan Stanley
New York
| $37K | -$93.5K | -2 | -67% |
|
10
Creative Planning
Overland Park,
Kansas
| $16K | – | – | – |
|
|
TCM
11
Tradewinds Capital Management
Bellingham,
Washington
| $13K | – | – | – |
|
|
FTUS
12
Flow Traders U.S.
New York
| $3K | -$93.5K | -2 | Closed |
|
LABD Hedge Fund Activity: Q3 2016 in Review
9 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily S&P Biotech Bear 3X ETF (LABD) for Q3 2016, worth a combined $3.98M — up 175% from $1.45M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new LABD positions and 1 closed out — a net gain of 3 holders — while 3 added to existing stakes and 1 trimmed.
The largest buyer was Virtu Financial, opening a new position worth an estimated $2.62M. The largest seller was Flow Traders U.S., exiting entirely with an estimated $93.5K sold.
- 9 institutional investors held Direxion Daily S&P Biotech Bear 3X ETF (LABD) as of Q3 2016, up from 6 in Q2 2016.
- Funds reported $3.98M of Direxion Daily S&P Biotech Bear 3X ETF stock for Q3 2016, up 175% quarter-over-quarter.
- 4 funds opened new Direxion Daily S&P Biotech Bear 3X ETF positions in Q3 2016 and 1 closed out, a net change of +3 holders.
- The largest Direxion Daily S&P Biotech Bear 3X ETF buyer in Q3 2016 was Virtu Financial, an estimated $2.62M added.
- The largest Direxion Daily S&P Biotech Bear 3X ETF seller in Q3 2016 was Flow Traders U.S., an estimated $93.5K sold.
Based on aggregated 13F filings for Q3 2016.